Related Experiment Video
Updated: Jul 5, 2025

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Endothelial dysfunction and cardiovascular diseases: The role of human induced pluripotent stem cells and tissue
Mary H C Florido1,2,3, Nicholas P Ziats1,4
1Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Insights
Novel therapies for cardiovascular disease (CVD) are crucial. Combining stem cell biology and bioengineering advances tissue engineering for CVD treatment, mimicking native tissues for better outcomes.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Cardiovascular Research
Background:
- Cardiovascular disease (CVD) is the leading global cause of mortality.
- Understanding CVD pathophysiology is vital for developing new treatments.
- Endothelial cell dysfunction plays a significant role in CVD.
Purpose of the Study:
- To review advancements in cardiovascular disease research.
- To highlight the synergy between stem cell biology and bioengineering.
- To discuss the impact on cardiovascular tissue engineering and treatment.
Main Methods:
- Review of recent studies on CVD, endothelial cells, and dysfunction.
- Exploration of stem cell biology techniques, including reprogramming human pluripotent stem cells.
- Discussion of bioengineering approaches using organic and inorganic biomaterials to mimic extracellular matrix.
Main Results:
- Stem cell technology enables generation of various cell types.
- Biomaterials facilitate in vitro recapitulation of organ structures.
- The integration of stem cell biology and bioengineering accelerates progress in CVD research.
Conclusions:
- The convergence of stem cell biology and bioengineering offers significant promise for cardiovascular disease treatment.
- Tissue engineering strategies are advancing cardiovascular device development.
- Further research in this interdisciplinary field is essential for novel therapeutic interventions.
Abstract:
Cardiovascular disease (CVD) remains to be the leading cause of death globally today and therefore the need for the development of novel therapies has become increasingly important in the cardiovascular field. The mechanism(s) behind the pathophysiology of CVD have been laboriously investigated in both stem cell and bioengineering laboratories. Scientific breakthroughs have paved the way to better mimic cell types of interest in recent years, with the ability to generate any cell type from reprogrammed human pluripotent stem cells. Mimicking the native extracellular matrix using both organic and inorganic biomaterials has allowed full organs to be recapitulated in vitro. In this paper, we will review techniques from both stem cell biology and bioengineering which have been fruitfully combined and have fueled advances in the cardiovascular disease field. We will provide a brief introduction to CVD, reviewing some of the recent studies as related to the role of endothelial cells and endothelial cell dysfunction. Recent advances and the techniques widely used in both bioengineering and stem cell biology will be discussed, providing a broad overview of the collaboration between these two fields and their overall impact on tissue engineering in the cardiovascular devices and implications for treatment of cardiovascular disease.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
EPS and iPS Cells in Disease Research
Stem Cell Culture

